Covidien
Covidien is a global medical device company, now a wholly-owned Medtronic subsidiary, that manufactures surgical sutures and respiratory monitoring devices for hospitals and healthcare providers worldwide.
- Company typePrivate
- Founded2007
- HeadquartersDublin, Ireland
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Covidien does
Covidien was a global medical device company headquartered in Dublin, Ireland, founded in 2007 and formerly listed on the NYSE under ticker COV, with 10,000+ employees. Following its 2015 acquisition by Medtronic, Covidien now operates as a wholly-owned subsidiary and brand within Medtronic's broader medical device portfolio, with its brand page hosted on Medtronic's website. The company was historically built through both organic development and aggressive M&A, completing roughly 19 acquisitions between 2007 and 2014 across neurovascular, vascular, GI endoscopy, bronchoscopy, patient monitoring, and surgical device categories.
Covidien's product portfolio centers on two core categories: surgical sutures (both monofilament sutures and general surgical suture products, where it is named as a key global competitor alongside Ethicon, B. Braun, and others) and respiratory monitoring devices (where Covidien LLC is identified as a key company in a market projected to reach $2.89B by 2030). Its historical franchises also included minimally invasive surgical devices, neurovascular stroke-treatment devices (via the MindFrame acquisition, now within Medtronic Neurovascular), capsule endoscopy (Given Imaging), electromagnetic navigation bronchoscopy (SuperDimension), brain/EEG monitoring (Aspect Medical Systems), and venous disease treatments (VNUS Medical Technologies).
The company's revenue model is B2B medical device sales to healthcare providers and hospitals globally, with horizontal segmentation across surgical supplies and patient monitoring categories. Pricing is not publicly disclosed in the available sources, and post-acquisition Covidien's financials are consolidated within Medtronic's reporting, with no independent cap table or ownership structure. The Covidien brand continues to surface in ongoing product litigation, particularly hernia mesh multidistrict litigation with 2,000+ federal lawsuits pending as of late 2025.
Covidien firmographics
Firmographics- Name
- Covidien
- Website
- https://covidien.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Acquired
- Headcount range
- 5,001–10,000 employees
- Short description
- Covidien is a global medical device company, now a wholly-owned Medtronic subsidiary, that manufactures surgical sutures and respiratory monitoring devices for hospitals and healthcare providers worldwide.
- Ownership category
- akta.pro rank
Covidien industry classification
Industry- Product category
- Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)
Keywords
Where Covidien is headquartered
LocationHeadquarters
- HQ city
- Dublin
- HQ country
- Ireland
- HQ region
- Europe
Markets served
Covidien business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Others
Covidien product offering
Product offeringCore offering
Covidien manufactures and sells medical devices for healthcare providers and hospitals, with a portfolio that includes monofilament and general surgical sutures and respiratory monitoring devices. The company is positioned as a key competitor in the global surgical sutures market (projected at $13.61 billion in 2025) and the respiratory monitoring devices market (projected to reach $2.89 billion by 2030). Following its 2015 acquisition by Medtronic, Covidien operates as an integrated brand within Medtronic's medical device portfolio.
Product overview
Covidien, now part of Medtronic, operates as a medical device company offering surgical sutures (both monofilament and general surgical suture products) and respiratory monitoring devices. The company is positioned as a key competitor in multiple medical device market segments including the surgical sutures market and respiratory monitoring devices market. Product portfolio includes monofilament sutures for surgical applications and respiratory monitoring equipment, competing alongside other major medical device manufacturers such as Ethicon, Medtronic, B. Braun, and others.
Differentiator
Problem solved
Functional benefit
Products and services
- Covidien Monofilament Sutures Monofilament sutures manufactured by Covidien for surgical applications including tissue closure in surgical procedures, used by healthcare providers and hospitals.
- Covidien Surgical Sutures General surgical sutures product line sold by Covidien for use in surgical procedures by healthcare providers and hospitals.
- Covidien Respiratory Monitoring Devices Respiratory monitoring devices manufactured by Covidien for clinical patient monitoring in healthcare settings, serving healthcare providers and hospitals.
Companies that use Covidien
Customer profileSegments1 record
Ideal customer profiles1 record
Covidien technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Covidien partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MindFramecoreCovidien acquired MindFrame (a neurovascular and stroke treatment device company) as part of its expansion into neurovascular medical devices. MindFrame is now part of Medtronic Neurovascular.
Recent moves6 records
Expansion highlights5 records
Covidien competitors and assessment
Company assessmentMarket position
Weaknesses4 records
Competitive moat5 records
Key risks4 records
Key highlights5 records
Customer concentration
Covidien social profiles
Digital presenceCovidien financial estimates
Financial estimateRevenue estimate
Valuation estimate
Covidien leadership team
Management profileNumber of profiles
Covidien funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Covidien M&A and investment
M&A and investmentM&A19 records
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Covidien
What does Covidien do?
Covidien manufactures and sells medical devices for healthcare providers and hospitals, with a portfolio that includes monofilament and general surgical sutures and respiratory monitoring devices. The company is positioned as a key competitor in the global surgical sutures market (projected at $13.61 billion in 2025) and the respiratory monitoring devices market (projected to reach $2.89 billion by 2030). Following its 2015 acquisition by Medtronic, Covidien operates as an integrated brand within Medtronic's medical device portfolio.
Is Covidien a public or private company?
Covidien is a private company. It is classified as corporate owned and is currently acquired.
When was Covidien founded?
Covidien was founded in 2007. It employs 5,001 to 10,000 people.
Where is Covidien based?
Covidien is headquartered in Dublin, Ireland, in the Europe region.
Does Covidien have an API?
No public API is recorded for Covidien.
What industry is Covidien in?
Covidien's product category is Medical Devices. Its primary akta.pro industry code is CRADAMAK, Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests). Its NAICS code is 339112 and its SIC code is 3841.